Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
Sponsor: Cleveland Clinic Akron General
Listed as NCT00973856, this NA trial focuses on Condylomata Acuminata and Epidermodysplasia Verruciformis and remains completed. Sponsored by Cleveland Clinic Akron General, it has been updated 12 times since 2009, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2023 — Jul 2024 [monthly]
Completed NA
-
Feb 2023 — Apr 2023 [monthly]
Completed NA
-
Jan 2023 — Feb 2023 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Feb 2021 — Dec 2022 [monthly]
Completed NA
-
Jan 2021 — Feb 2021 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Aug 2019 — Feb 2020 [monthly]
Completed NA
-
Jun 2018 — Aug 2019 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Sep 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cleveland Clinic Akron General
For direct contact, visit the study record on ClinicalTrials.gov .